|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-4.24/-2.31
|
企业价值
9.88M
|
资产负债 |
每股账面净值
-0.31
|
现金流量 |
现金流量率
--
|
损益表 |
收益
0
|
每股收益
0.05
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/18 01:09 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS. |